Pharmaceuticals, Biotechnology and Life Sciences
GARCHING, Germany–(BUSINESS WIRE)–ITM AG, a privately held radiopharmaceutical biotech company, announced today that is has signed two strategic agreements with Telix Pharmaceuticals Limited for the global supply of ITM’s highly pure therapeutic radi…
BOSTON–(BUSINESS WIRE)–PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating dise…
BOSTON–(BUSINESS WIRE)–PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating dise…
BOSTON–(BUSINESS WIRE)–PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating dise…
Cash position of €62 million at year-end provides runway until the end of H2 2022
Enrolment of SENS-401 Phase 2 SSNHL clinical study progressing
Expanding internal gene therapy capabilities including AAV, analytical and process development
Repo…
ImmunoPrecise and Genmab enter into a technology partnership targeting infectious disease
ImmunoPrecise and Litevax advance SARS-CoV-2 vaccine candidate for further pre-clinical evaluation
Commenced trading on Nasdaq stock exchange
Announced po…
Substantial progress in priority development pathway in head and neck cancer with clinical registration plan announced, Fast Track designation granted by US Food and Drug Administration, and new data from phase I dose expansion showing 83% objective …
BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) released details supporting the Orphan Designa…
Organon Proposed Board of Directors To Have More Women Than Any S&P 500 Healthcare Company
Investor Day Planned for May 3 Ahead of Spinoff in Late Second Quarter 2021
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD o…
Organon Proposed Board of Directors To Have More Women Than Any S&P 500 Healthcare Company
Investor Day Planned for May 3 Ahead of Spinoff in Late Second Quarter 2021
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD o…